Pages that link to "Q24647759"
Jump to navigation
Jump to search
The following pages link to Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway (Q24647759):
Displaying 46 items.
- Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation (Q24606703) (← links)
- RGDechi-hCit: αvβ3 selective pro-apoptotic peptide as potential carrier for drug delivery into melanoma metastatic cells (Q28543148) (← links)
- Retracted: BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells (Q33690185) (← links)
- Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair (Q33709432) (← links)
- Integrin inhibitor suppresses bevacizumab-induced glioma invasion (Q33912329) (← links)
- Mesenchymal migration as a therapeutic target in glioblastoma (Q34002994) (← links)
- Integrins and bone metastasis: integrating tumor cell and stromal cell interactions (Q34441622) (← links)
- Integrin targeted therapeutics (Q34912684) (← links)
- Anti-angiogenic peptides for cancer therapeutics (Q35043016) (← links)
- Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5. (Q35111316) (← links)
- Cilengitide induces autophagy-mediated cell death in glioma cells (Q35133418) (← links)
- Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium (Q35218871) (← links)
- Differential growth inhibition of cerebral metastases by anti-angiogenic compounds (Q35304863) (← links)
- A novel 2.5D culture platform to investigate the role of stiffness gradients on adhesion-independent cell migration (Q35327049) (← links)
- Targeting SRC in glioblastoma tumors and brain metastases: Rationale and preclinical studies (Q35539318) (← links)
- Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer (Q36065429) (← links)
- The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines (Q36697070) (← links)
- Gene expression profiling of the anti-glioma effect of Cilengitide (Q36824282) (← links)
- Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models (Q36884277) (← links)
- In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines (Q37277108) (← links)
- Hydrostatic Compress Force Enhances the Viability and Decreases the Apoptosis of Condylar Chondrocytes through Integrin-FAK-ERK/PI3K Pathway (Q37465510) (← links)
- Mechanisms and markers of vascular damage in ANCA-associated vasculitis (Q37622945) (← links)
- Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer (Q37750751) (← links)
- Integrins as receptor targets for neurological disorders (Q37974737) (← links)
- Angiogenesis in cancer: Anti-VEGF escape mechanisms (Q38389975) (← links)
- Effects of cilengitide in osteoclast maturation and behavior. (Q38849470) (← links)
- Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology. (Q38869424) (← links)
- Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists. (Q38901081) (← links)
- Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin. (Q38950364) (← links)
- Integrin inhibition promotes atypical anoikis in glioma cells (Q39031255) (← links)
- Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway (Q39060605) (← links)
- Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? (Q39210287) (← links)
- The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress (Q39411316) (← links)
- Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment (Q42353677) (← links)
- A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells (Q42562704) (← links)
- Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression (Q43501092) (← links)
- Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed-effects analysis (Q46894458) (← links)
- Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis (Q47159400) (← links)
- Access to site-specific Fc-cRGD peptide conjugates through streamlined expressed protein ligation. (Q48310799) (← links)
- Evolutionarily conserved and conformationally constrained short peptides might serve as DNA recognition elements in intrinsically disordered regions. (Q51099642) (← links)
- The evaluation of human tenon's fibroblasts and endothelial cell responses to antifibrotics alone and in combination with α-tocopherol. (Q53056599) (← links)
- Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. (Q54935910) (← links)
- Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides (Q57975614) (← links)
- CTHRC1 mediates multiple pathways regulating cell invasion, migration and adhesion in glioma (Q92840547) (← links)
- Spatial heterogeneity of cell-matrix adhesive forces predicts human glioblastoma migration (Q98467278) (← links)
- EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells (Q100437394) (← links)